Neuralink to Begin Brain Chip Trials in Great Britain for Paralysis Patients
- tech360.tv
- 2 hours ago
- 1 min read
Neuralink, the brain implant company founded by Elon Musk, will begin clinical trials in Great Britain to test its brain chip technology on patients with severe paralysis.
The company announced Thursday that it is partnering with University College London Hospitals Trust and Newcastle Hospitals to conduct the study.
The trial will evaluate how Neuralink’s brain chips allow participants to control digital and physical tools using only their thoughts.
Eligible participants include individuals living with paralysis caused by spinal cord injuries or Amyotrophic Lateral Sclerosis (ALS), a progressive nervous system disease.
Neuralink began human trials in 2024 after addressing safety concerns raised by the U.S. Food and Drug Administration, which had initially rejected the company’s application in 2022.
Currently, five patients with severe paralysis are using the device to interact with technology through thought alone, according to Neuralink.
The company raised USD 650 million in its most recent funding round last month.
Founded in 2016, Neuralink has secured approximately USD 1.3 billion in total funding and is valued at around USD 9 billion, according to media reports citing PitchBook.
Neuralink to launch brain chip trials in Great Britain for paralysis patients
Study conducted with University College London Hospitals and Newcastle Hospitals
Participants will control tools using thoughts via implanted chips
Source: REUTERS